Growth Metrics

OptimizeRx (OPRX) Receivables - Other (2016 - 2026)

OptimizeRx's Receivables - Other history spans 10 years, with the latest figure at $3.9 million for Q4 2025.

  • On a quarterly basis, Receivables - Other rose 21.66% to $3.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.9 million, a 21.66% increase, with the full-year FY2025 number at $3.9 million, up 21.66% from a year prior.
  • Receivables - Other hit $3.9 million in Q4 2025 for OptimizeRx, up from $3.7 million in the prior quarter.
  • Over the last five years, Receivables - Other for OPRX hit a ceiling of $6.1 million in Q4 2023 and a floor of $2.1 million in Q4 2021.
  • Historically, Receivables - Other has averaged $4.0 million across 5 years, with a median of $3.7 million in 2025.
  • Biggest five-year swings in Receivables - Other: soared 178.77% in 2021 and later tumbled 46.67% in 2024.
  • Tracing OPRX's Receivables - Other over 5 years: stood at $2.1 million in 2021, then skyrocketed by 69.73% to $3.6 million in 2022, then soared by 69.62% to $6.1 million in 2023, then crashed by 46.67% to $3.2 million in 2024, then increased by 21.66% to $3.9 million in 2025.
  • Business Quant data shows Receivables - Other for OPRX at $3.9 million in Q4 2025, $3.7 million in Q3 2025, and $3.5 million in Q2 2025.